Genetic bases of comorbidity between mood disorders and migraine: Possible role of serotonin transporter gene

Elena Marino, Bongiorno Fanny, Cristina Lorenzi, Adele Pirovano, Linda Franchini, Cristina Colombo, Placido Bramanti, Enrico Smeraldi

Research output: Contribution to journalArticle

Abstract

Migraine is a common neurological disease in the population and the most associated headache with mood disorder. Although the relationship between migraine and depression is well known, the reverse correlation between depression and migraine was observed but not well understood. The tight relationship between the two disturbances is also suggested by the efficacy of antidepressants for migraine treatment. Starting from these observations, we can presume that both migraine and depression have overlapping biological bases. The main target of antidepressant treatments belonging to the serotonin selective reuptake inhibitors (SSRI) type is the serotonin transporter (SERT); a well-studied polymorphic variant, in the promoter region of the gene (SERTPR), has been demonstrated to influence the availability of serotonin in the synaptic cleft. So, our group studied the possible role of the SERT as a risk factor, both for migraine and mood disorders, in a sample of 96 patients affected by both pathologies.

Original languageEnglish
Pages (from-to)387-391
Number of pages5
JournalNeurological Sciences
Volume31
Issue number3
DOIs
Publication statusPublished - Jun 2010

Keywords

  • Genetics
  • Migraine
  • Mood disorders
  • Serotonin transporter

ASJC Scopus subject areas

  • Medicine(all)
  • Dermatology
  • Clinical Neurology
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Genetic bases of comorbidity between mood disorders and migraine: Possible role of serotonin transporter gene'. Together they form a unique fingerprint.

  • Cite this